Doxazosin Tablet
Product Images NDC 50090-5773

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-5773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Table 1 (Doxazosin Fig1)

Table 1 (Doxazosin Fig1)
This is a table summarizing the effectiveness data of placebo-controlled trials. The table shows maximum flow rate and symptom score data for each study, including the number of patients, baseline score, and change in score. Study 1 showcased maximum dose of Vatinum Fo, Study 2 showed fixed-dose and titration for 14 weeks, and Study 3 showed titration for 12 weeks. Different dosages of doxazosin were also compared to placebo. The questionnaire used for evaluating symptoms varied among the studies and ranged from 0 to 39; however, specific scores were not provided.*
FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Figure 1 – Study 1 (Doxazosin Fig2)
Mean increase in maximum urinary flow rate and mean change in total symptom score from baseline were evaluated in a study with a placebo and doxazosin treatment. The study was conducted for a duration of weeks, and the maximum dosage for doxazosin was 8 mg. Compared to placebo, the results showed a statistically significant improvement (*p<0.05) in maximum urinary flow rate with doxazosin treatment. Furthermore, statistically significant improvement (+p < 0.05) in total symptom score was observed in comparison to baseline for both placebo and doxazosin treatment.*
FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical Structure (Doxazosin Str)
FDA Label Image

Label Image (Lbl500905773)

Label Image (Lbl500905773)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.